These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8333612)

  • 1. Endocrine disorders (parathyroid hormone).
    Gupta MK; Khoo D
    Anal Chem; 1993 Jun; 65(12):378R-381R. PubMed ID: 8333612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of circulating parathyroid hormone.
    Woodhead JS
    Clin Biochem; 1990 Feb; 23(1):17-21. PubMed ID: 2184952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic applicability of intact and midregion/C-terminal parathyroid hormone assays in calcium metabolic disorders.
    Rudnicki M; McNair P; Transbøl I; Lindgren P
    J Intern Med; 1990 Nov; 228(5):465-70. PubMed ID: 2254716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.
    Morita A; Tabata T; Koyama H; Emoto M; Inoue T; Miki T; Nishizawa Y; Morii H
    Clin Nephrol; 1992 Sep; 38(3):154-7. PubMed ID: 1395169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum intact parathyroid hormone concentration measured by a two-site immunoradiometric assay in normal subjects and patients with various parathyroid disorders.
    Okazaki R; Matsumoto T; Furukawa Y; Fujimoto Y; Niimi H; Seino Y; Fujita T; Nagataki S; Ogata E
    Endocrinol Jpn; 1992 Feb; 39(1):115-20. PubMed ID: 1606913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
    Gao P; D'Amour P
    Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of parathyroid hormone.
    Endres DB; Villanueva R; Sharp CF; Singer FR
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):611-29. PubMed ID: 2673765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism.
    Endres DB; Villanueva R; Sharp CF; Singer FR
    Clin Chem; 1991 Feb; 37(2):162-8. PubMed ID: 1993319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in parathyroid disease and parathyroid hormone assays.
    Garon JE; Liu N
    Clin Leadersh Manag Rev; 2002; 16(3):187-91. PubMed ID: 12046277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoassays for the detection of parathyroid hormone.
    Jüppner H; Potts JT
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function.
    Gao P; Scheibel S; D'Amour P; John MR; Rao SD; Schmidt-Gayk H; Cantor TL
    J Bone Miner Res; 2001 Apr; 16(4):605-14. PubMed ID: 11315988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism.
    Nussbaum SR; Potts JT
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-site assay of intact parathyroid hormone in primary hyperparathyroidism: studies in basal conditions, following adenoma removal and during calcium and EDTA infusion.
    Mazzuoli G; Minisola S; Scarnecchia L; Pacitti MT; Carnevale V; Romagnoli E; Bigi F; Bianchi G
    Clin Chim Acta; 1990 Oct; 190(3):239-48. PubMed ID: 2123754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of minor increase in serum calcium on the immunoheterogeneity of parathyroid hormone in healthy subjects and in patients with primary hyperparathyroidism.
    Ahrén B; Bergenfelz A
    Horm Res; 1995; 43(6):294-9. PubMed ID: 7607615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.
    Silverberg SJ; Gao P; Brown I; LoGerfo P; Cantor TL; Bilezikian JP
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4725-30. PubMed ID: 14557447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoheterogeneity of parathyroid hormone in parathyroid cysts: diagnostic implications.
    Birnbaum J; Van Herle AJ
    J Endocrinol Invest; 1989 Dec; 12(11):831-6. PubMed ID: 2614019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of a radioimmunoassay for parathyroid hormone in human serum.
    Almqvist S; Hjern B; Wästhed B
    Acta Endocrinol (Copenh); 1975 Mar; 78(3):493-509. PubMed ID: 1173015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of parathyroid hormone and application of parathyroid hormone in intraoperative monitoring.
    Sokoll LJ
    Clin Lab Med; 2004 Mar; 24(1):199-216. PubMed ID: 15157563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.